InMed Announces Successful Completion of Pharmacokinetic Studies in Large Animal Model for Its Alzheimer’s Disease Candidate INM-901
Data will support design and planning of first in human clinical trials Preparing for pre-IND meeting with the FDA InMed Pharmaceuticals Inc. (NASDAQ:









